Advertisement
Advertisement
GKOS
Glaukos Corporation
143.67
USDSponsored
+26.71
+22.84%
Apr 30, 16:00 UTC -4
Closed
After-Market
142.71
-0.96
-0.67%
GKOS Earnings Reports
Positive Surprise Ratio
GKOS beat 29 of 42 last estimates.
69%
Next Report
Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$147.71M
/-$0.21
Implied change from Q1 26 (Revenue/ EPS)
-1.90%
/+16.67%
Implied change from Q2 25 (Revenue/ EPS)
+19.00%
/-12.50%
Glaukos Corporation earnings per share and revenue
On Apr 29, 2026, GKOS reported earnings of -0.18 USD per share (EPS) for Q1 26, beating the estimate of -0.27 USD, resulting in a 35.30% surprise. Revenue reached 150.57 million, compared to an expected 139.65 million, with a 7.82% difference. The market reacted with a +22.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 15 analysts forecast an EPS of -0.21 USD, with revenue projected to reach 147.71 million USD, implying an increase of 16.67% EPS, and decrease of -1.90% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Integer Holdings Corporation
Report Date
Apr 30, 2026 For Q1 26
Estimate
$1.21
Actual
$1.20
Surprise
-0.84%
Thermo Fisher Scientific, Inc.
Report Date
Apr 23, 2026 For Q1 26
Estimate
$5.28
Actual
$5.44
Surprise
+2.84%
Intuitive Surgical Inc.
Report Date
Apr 21, 2026 For Q1 26
Estimate
$2.14
Actual
$2.50
Surprise
+16.77%
Edwards Lifesciences Corp
Report Date
Apr 23, 2026 For Q1 26
Estimate
$0.74
Actual
$0.78
Surprise
+4.17%
DexCom, Inc.
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.47
Actual
$0.56
Surprise
+17.03%
Axogen, Inc. Common Stock
Report Date
Apr 28, 2026 For Q1 26
Estimate
$0.07
Actual
$0.07
Surprise
-4.50%
PROCEPT BioRobotics Corporation Common Stock
Report Date
Apr 29, 2026 For Q1 26
Estimate
-$0.56
Actual
-$0.56
Surprise
+1.34%
Opko Health Inc.
Report Date
Apr 28, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+0.99%
Beta Bionics, Inc. Common Stock
Report Date
Apr 21, 2026 For Q1 26
Estimate
-$0.49
Actual
-$0.49
Surprise
+1.69%
OrthoPediatrics Corp. Common Stock
Report Date
Apr 30, 2026 For Q1 26
Estimate
-$0.48
Actual
-$0.42
Surprise
+13.53%
FAQ
What were Glaukos Corporation's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Glaukos Corporation reported EPS of -$0.18, beating estimates by 35.3%, and revenue of $150.57M, 7.82% above expectations.
How did the market react to Glaukos Corporation's Q1 2026 earnings?
The stock price moved up 22.84%, changed from $116.96 before the earnings release to $143.67 the day after.
When is Glaukos Corporation expected to report next?
The next earning report is scheduled for Jul 28, 2026.
What are the forecasts for Glaukos Corporation's next earnings report?
Based on 15
analysts, Glaukos Corporation is expected to report EPS of -$0.21 and revenue of $147.71M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement